PERK — Perk Labs Balance Sheet
0.000.00%
TechnologyHighly SpeculativeMicro Cap
Annual balance sheet for Perk Labs, fiscal year end - November 30th, CAD millions except per share, conversion factor applied.
R2018 November 30th | 2019 November 30th | 2020 November 30th | 2021 November 30th | 2022 November 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 5.65 | 3.63 | 1.07 | 2.28 | 0.326 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.226 | 0.021 | 0.057 | 0.03 | 0.01 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 7.56 | 3.71 | 1.22 | 2.4 | 0.438 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.316 | 0.032 | 0.23 | 0.135 | 0.04 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Total Assets | 12.5 | 4.73 | 1.64 | 3.18 | 0.478 |
Payable / Accrued | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.503 | 0.368 | 0.423 | 0.402 | 0.25 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 0.503 | 0.368 | 0.58 | 0.459 | 0.25 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 12 | 4.36 | 1.06 | 2.73 | 0.228 |
Total Liabilities & Shareholders' Equity | 12.5 | 4.73 | 1.64 | 3.18 | 0.478 |
Total Common Shares Outstanding |